Search research articles
Contact Us
Filters
Showing results (131-140 of 196) with videos related to
Page
of 20
Sort By:
Journal of Neurology
|
July 1, 2024
Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE study
Anja Ophey, Kathrin Wirtz, Steffen Wolfsgruber, et al.
Annals of Clinical and Translational Neurology
|
October 3, 2025
Scoliosis Surgery in a Patient With Advanced Friedreich's Ataxia-It Is Not Too Late
Kathrin Reetz, Stella A Lischewski, Jörg B Schulz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)
Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.
Brain : a Journal of Neurology
|
February 21, 2013
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, et al.
Journal of Neurology
|
June 16, 2026
Cerebellar cognitive-affective syndrome in Friedreich Ataxia
Emilien Petit, Sabrina Sayah, Elisabetta Indelicato, et al.
Neurology. Genetics
|
December 16, 2022
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)
Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 23, 2017
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Sanne K Meles, David Vadasz, Remco J Renken, et al.
European Journal of Neurology
|
October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)
Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
Neurological Research and Practice
|
December 16, 2020
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Kathrin Reetz, Ralf-Dieter Hilgers, Susanne Isfort, et al.
Human Brain Mapping
|
September 7, 2017
On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification
Rachel N Pläschke, Edna C Cieslik, Veronika I Müller, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 196) with videos related to
Sort By:
Page
of 20
Journal of Neurology
|
July 1, 2024
Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE study
Anja Ophey, Kathrin Wirtz, Steffen Wolfsgruber, et al.
Annals of Clinical and Translational Neurology
|
October 3, 2025
Scoliosis Surgery in a Patient With Advanced Friedreich's Ataxia-It Is Not Too Late
Kathrin Reetz, Stella A Lischewski, Jörg B Schulz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)
Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.
Brain : a Journal of Neurology
|
February 21, 2013
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, et al.
Journal of Neurology
|
June 16, 2026
Cerebellar cognitive-affective syndrome in Friedreich Ataxia
Emilien Petit, Sabrina Sayah, Elisabetta Indelicato, et al.
Neurology. Genetics
|
December 16, 2022
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)
Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 23, 2017
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Sanne K Meles, David Vadasz, Remco J Renken, et al.
European Journal of Neurology
|
October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)
Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
Neurological Research and Practice
|
December 16, 2020
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Kathrin Reetz, Ralf-Dieter Hilgers, Susanne Isfort, et al.
Human Brain Mapping
|
September 7, 2017
On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification
Rachel N Pläschke, Edna C Cieslik, Veronika I Müller, et al.
Page
of 20